Fang Xiao

End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB

Da Huang, Di Wu, Peng Wang et al. · Journal of Hepatology · 2022 · 93 citations · Full text

The peroxisome proliferator-activated receptor γ agonist pioglitazone prevents NF-κB activation in cisplatin nephrotoxicity through the reduction of p65 acetylation via the AMPK-SIRT1/p300 pathway

Jiong Zhang, Ying Zhang, Fang Xiao et al. · Biochemical Pharmacology · 2015 · 91 citations

Ampk-sirt1/p300 Pathway, Chemoprevention Strategy, Medicine +8

Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth

Galina Gritsina, Fang Xiao, Shane W. O’Brien et al. · Molecular Cancer Therapeutics · 2015 · 90 citations · Full text

Immunology, Gynecology, Cancer Biology +17

HMGB1-TLR4 signaling participates in renal ischemia reperfusion injury and could be attenuated by dexamethasone-mediated inhibition of the ERK/NF-κB pathway.

Jiong Zhang, Jumei Xia, Ying Zhang et al. · PubMed · 2016 · 54 citations · Full text

Erk/nf-κb Pathway, Renal Pathology, Immunology +22

N⁶-(2-hydroxyethyl)-adenosine from <i>Cordyceps cicadae</i> protects against diabetic kidney disease via alleviation of oxidative stress and inflammation

Xiaohong Wang, Ai-Qiong Qin, Fang Xiao et al. · Journal of Food Biochemistry · 2018 · 34 citations